Los efectos sobre control glucmico y FRCV asociados a SEMA 2,4mg en el programa STEP son cualitativamente similares, pero cuantitativamente superiores a los observados con LIRA 3mg, en posible relacin con la diferente prdida ponderal16
DR Symptoms May Include: Floaters or flashes of light in field of vision Blurred or fluctuating vision Difficulty seeing at night Partial or total vision loss Eye pain or redness Ozempic and the Risk of DR According to the FDA Adverse Event Reporting System, Ozempic and other GLP-1 drugs have been associated with a significantly higher number of diabetic retinopathy complaints compared to other diabetes medications
No formal PRISMA methodology, risk-of-bias assessment, or evidence grading system was applied, as the aim of this work was to provide a critical narrative synthesis of the current evidence rather than a systematic quantitative assessment
The data was analyzed with FlowJo: median fluorescence emission at 525 nm from living, single cells was measured
Clinical data support administration on the same day or in the same injection (if mixed), no proven pharmacokinetic interactions